Gene Symbol | Gene ID | Gene Info |
---|---|---|
Sox2
|
ENSMUSG00000074637.4 | Sox2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
Sox2 | chr3_34648572_34651394 | 422 | 0.731272 | 0.78 | 2.1e-13 | Click! |
Sox2 | chr3_34652462_34653573 | 2612 | 0.156553 | 0.75 | 6.0e-12 | Click! |
Sox2 | chr3_34651759_34652037 | 1493 | 0.256133 | 0.73 | 4.3e-11 | Click! |
Sox2 | chr3_34648019_34648437 | 2177 | 0.183947 | 0.61 | 1.8e-07 | Click! |
Sox2 | chr3_34647222_34647420 | 3084 | 0.144562 | 0.24 | 6.3e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_29143400_29144848 | 43.14 |
Soga3 |
SOGA family member 3 |
65 |
0.5 |
chrX_143930842_143933141 | 29.93 |
Dcx |
doublecortin |
1059 |
0.64 |
chr8_70119024_70120981 | 28.55 |
Ncan |
neurocan |
871 |
0.35 |
chr9_52148115_52149635 | 26.61 |
Zc3h12c |
zinc finger CCCH type containing 12C |
19236 |
0.18 |
chr8_123410787_123412789 | 21.43 |
Tubb3 |
tubulin, beta 3 class III |
198 |
0.84 |
chr8_123413418_123414506 | 21.24 |
Tubb3 |
tubulin, beta 3 class III |
2372 |
0.11 |
chr5_88583963_88584847 | 20.79 |
Rufy3 |
RUN and FYVE domain containing 3 |
611 |
0.7 |
chr2_6883618_6884699 | 20.72 |
Gm13389 |
predicted gene 13389 |
112 |
0.85 |
chr13_20473087_20474265 | 20.23 |
Gm32036 |
predicted gene, 32036 |
186 |
0.89 |
chr13_34126566_34127191 | 19.41 |
Tubb2b |
tubulin, beta 2B class IIB |
3476 |
0.13 |
chr15_72807706_72808811 | 18.59 |
Peg13 |
paternally expressed 13 |
2066 |
0.4 |
chr10_34299043_34301066 | 18.51 |
Tspyl4 |
TSPY-like 4 |
798 |
0.4 |
chr11_76466993_76468433 | 18.01 |
Abr |
active BCR-related gene |
585 |
0.77 |
chr3_34652462_34653573 | 16.69 |
Sox2 |
SRY (sex determining region Y)-box 2 |
2612 |
0.16 |
chr4_107679769_107680930 | 16.67 |
Dmrtb1 |
DMRT-like family B with proline-rich C-terminal, 1 |
611 |
0.63 |
chr14_66344363_66345813 | 16.25 |
Stmn4 |
stathmin-like 4 |
707 |
0.65 |
chr10_18408068_18409081 | 16.10 |
Nhsl1 |
NHS-like 1 |
899 |
0.67 |
chr4_5724213_5725550 | 15.90 |
Fam110b |
family with sequence similarity 110, member B |
569 |
0.81 |
chr4_116223265_116224130 | 15.64 |
Pik3r3 |
phosphoinositide-3-kinase regulatory subunit 3 |
2001 |
0.23 |
chr10_80300884_80302968 | 15.60 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
106 |
0.9 |
chr4_9269280_9270516 | 15.41 |
Clvs1 |
clavesin 1 |
551 |
0.81 |
chr1_136132801_136134260 | 15.29 |
Kif21b |
kinesin family member 21B |
2076 |
0.19 |
chr8_54954519_54955779 | 15.10 |
Gpm6a |
glycoprotein m6a |
306 |
0.88 |
chr8_41054476_41055299 | 14.63 |
Mtus1 |
mitochondrial tumor suppressor 1 |
93 |
0.95 |
chr3_8509825_8511666 | 14.53 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr6_93911862_93913573 | 14.42 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
213 |
0.95 |
chr19_22447648_22448999 | 14.04 |
Trpm3 |
transient receptor potential cation channel, subfamily M, member 3 |
91 |
0.63 |
chr10_69705909_69707430 | 14.03 |
Ank3 |
ankyrin 3, epithelial |
191 |
0.97 |
chr18_59062200_59063436 | 13.94 |
Minar2 |
membrane integral NOTCH2 associated receptor 2 |
307 |
0.94 |
chr18_72347538_72348154 | 13.90 |
Dcc |
deleted in colorectal carcinoma |
3171 |
0.38 |
chr7_45784257_45784949 | 13.85 |
Sult2b1 |
sulfotransferase family, cytosolic, 2B, member 1 |
66 |
0.88 |
chr9_110053895_110054422 | 13.82 |
Map4 |
microtubule-associated protein 4 |
2106 |
0.22 |
chr15_73021529_73022598 | 13.81 |
Trappc9 |
trafficking protein particle complex 9 |
33747 |
0.18 |
chr4_33926104_33927188 | 13.67 |
Cnr1 |
cannabinoid receptor 1 (brain) |
444 |
0.88 |
chrX_136590440_136591154 | 13.63 |
Tceal3 |
transcription elongation factor A (SII)-like 3 |
45 |
0.96 |
chr15_98989928_98991865 | 13.35 |
4930578M01Rik |
RIKEN cDNA 4930578M01 gene |
5002 |
0.1 |
chr15_98983254_98984205 | 13.35 |
4930578M01Rik |
RIKEN cDNA 4930578M01 gene |
102 |
0.93 |
chr17_78508180_78509392 | 13.19 |
Vit |
vitrin |
614 |
0.7 |
chr3_158559356_158560580 | 13.11 |
Lrrc7 |
leucine rich repeat containing 7 |
1368 |
0.57 |
chrX_152643367_152644550 | 13.05 |
Shroom2 |
shroom family member 2 |
34 |
0.98 |
chr9_41378412_41379411 | 12.92 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
2350 |
0.27 |
chr7_139086002_139087206 | 12.88 |
Dpysl4 |
dihydropyrimidinase-like 4 |
576 |
0.74 |
chr7_51629095_51630495 | 12.85 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
315 |
0.88 |
chr3_68573207_68574269 | 12.83 |
Schip1 |
schwannomin interacting protein 1 |
1493 |
0.45 |
chr6_134886811_134888239 | 12.82 |
Gpr19 |
G protein-coupled receptor 19 |
243 |
0.87 |
chr19_47017426_47018238 | 12.78 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
2679 |
0.17 |
chr12_27335791_27336166 | 12.69 |
Sox11 |
SRY (sex determining region Y)-box 11 |
6596 |
0.3 |
chr17_93198991_93201483 | 12.66 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
302 |
0.89 |
chr16_16558986_16560577 | 12.52 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
209 |
0.94 |
chr2_158606690_158608449 | 12.46 |
Gm14204 |
predicted gene 14204 |
3021 |
0.15 |
chr5_37245879_37246957 | 12.22 |
Crmp1 |
collapsin response mediator protein 1 |
573 |
0.76 |
chr12_29529828_29531185 | 12.22 |
Gm20208 |
predicted gene, 20208 |
609 |
0.74 |
chr7_92234907_92236280 | 12.17 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
466 |
0.88 |
chr1_184997307_184998530 | 12.09 |
Mark1 |
MAP/microtubule affinity regulating kinase 1 |
1557 |
0.41 |
chr5_111424407_111425623 | 12.05 |
Gm43119 |
predicted gene 43119 |
1426 |
0.38 |
chr1_168426195_168428871 | 12.03 |
Pbx1 |
pre B cell leukemia homeobox 1 |
3971 |
0.3 |
chr13_78189592_78191761 | 11.96 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
233 |
0.9 |
chr4_122998794_122999794 | 11.94 |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
45 |
0.97 |
chr9_91366433_91367646 | 11.90 |
Zic1 |
zinc finger protein of the cerebellum 1 |
1229 |
0.26 |
chr12_72235592_72237232 | 11.89 |
Rtn1 |
reticulon 1 |
136 |
0.97 |
chrX_134295383_134296942 | 11.87 |
Tmem35a |
transmembrane protein 35A |
937 |
0.52 |
chrX_58032839_58033176 | 11.79 |
Zic3 |
zinc finger protein of the cerebellum 3 |
1997 |
0.41 |
chr5_19907724_19909563 | 11.79 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
682 |
0.82 |
chr12_29528407_29529244 | 11.76 |
Myt1l |
myelin transcription factor 1-like |
424 |
0.85 |
chr1_66322405_66322814 | 11.72 |
Map2 |
microtubule-associated protein 2 |
507 |
0.79 |
chr13_34128849_34129198 | 11.71 |
Tubb2b |
tubulin, beta 2B class IIB |
1331 |
0.28 |
chr12_72234504_72235243 | 11.67 |
Rtn1 |
reticulon 1 |
866 |
0.66 |
chr8_94995272_94995731 | 11.64 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
160 |
0.93 |
chr1_9601164_9602408 | 11.59 |
Vxn |
vexin |
587 |
0.67 |
chr3_17790851_17791260 | 11.58 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1098 |
0.49 |
chrX_169827749_169828991 | 11.47 |
Mid1 |
midline 1 |
211 |
0.96 |
chrX_105390628_105392456 | 11.41 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
212 |
0.93 |
chr5_131532921_131534054 | 11.38 |
Auts2 |
autism susceptibility candidate 2 |
910 |
0.58 |
chr10_18470218_18471289 | 11.29 |
Nhsl1 |
NHS-like 1 |
772 |
0.72 |
chr13_83740463_83741042 | 11.26 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1889 |
0.2 |
chr9_41585694_41587243 | 11.22 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1301 |
0.29 |
chr15_99704098_99705242 | 11.19 |
Gm34939 |
predicted gene, 34939 |
694 |
0.3 |
chr1_74892200_74893701 | 11.09 |
Cryba2 |
crystallin, beta A2 |
58 |
0.95 |
chr8_94994139_94995207 | 11.04 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
77 |
0.95 |
chr2_65566848_65567533 | 11.00 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
302 |
0.92 |
chr1_177446374_177448525 | 10.97 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
1628 |
0.31 |
chr12_12722998_12723739 | 10.96 |
3732407C23Rik |
RIKEN cDNA 3732407C23 gene |
507 |
0.78 |
chr8_65617917_65619195 | 10.80 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
31 |
0.99 |
chr13_109442519_109443753 | 10.72 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
953 |
0.73 |
chr14_75963198_75963625 | 10.69 |
Kctd4 |
potassium channel tetramerisation domain containing 4 |
8402 |
0.18 |
chr9_36821403_36822795 | 10.65 |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
235 |
0.9 |
chr2_52038470_52039720 | 10.65 |
Tnfaip6 |
tumor necrosis factor alpha induced protein 6 |
1086 |
0.54 |
chr8_12399326_12400483 | 10.64 |
Gm25239 |
predicted gene, 25239 |
3501 |
0.16 |
chr12_117688775_117690161 | 10.63 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
512 |
0.83 |
chr8_117259792_117260803 | 10.55 |
Cmip |
c-Maf inducing protein |
3180 |
0.33 |
chr4_121230932_121231762 | 10.54 |
Gm12890 |
predicted gene 12890 |
3874 |
0.2 |
chr7_79505833_79506958 | 10.48 |
Mir9-3 |
microRNA 9-3 |
1131 |
0.28 |
chr5_115431565_115432258 | 10.42 |
Msi1 |
musashi RNA-binding protein 1 |
1306 |
0.22 |
chrX_133684830_133685971 | 10.35 |
Pcdh19 |
protocadherin 19 |
409 |
0.91 |
chr19_47016965_47017116 | 10.18 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
1887 |
0.21 |
chr2_181764652_181765649 | 10.18 |
Myt1 |
myelin transcription factor 1 |
1818 |
0.27 |
chr16_18213980_18215144 | 10.14 |
4933432I09Rik |
RIKEN cDNA 4933432I09 gene |
699 |
0.36 |
chrX_7919510_7921219 | 10.07 |
Pcsk1n |
proprotein convertase subtilisin/kexin type 1 inhibitor |
542 |
0.52 |
chr14_100374663_100375528 | 10.04 |
Gm26367 |
predicted gene, 26367 |
43388 |
0.15 |
chr1_194622071_194623282 | 10.00 |
Plxna2 |
plexin A2 |
2851 |
0.26 |
chr7_62420525_62420893 | 9.99 |
Mkrn3 |
makorin, ring finger protein, 3 |
570 |
0.69 |
chr12_29536509_29537451 | 9.99 |
Myt1l |
myelin transcription factor 1-like |
1758 |
0.36 |
chr1_172014368_172015755 | 9.91 |
Vangl2 |
VANGL planar cell polarity 2 |
6032 |
0.15 |
chr2_181763361_181764530 | 9.86 |
Myt1 |
myelin transcription factor 1 |
613 |
0.66 |
chr3_108410436_108412210 | 9.85 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
4229 |
0.11 |
chr1_12988619_12989682 | 9.83 |
Slco5a1 |
solute carrier organic anion transporter family, member 5A1 |
1764 |
0.4 |
chr18_16805598_16806159 | 9.82 |
Cdh2 |
cadherin 2 |
2584 |
0.29 |
chr1_32174771_32175297 | 9.79 |
Khdrbs2 |
KH domain containing, RNA binding, signal transduction associated 2 |
2147 |
0.41 |
chr2_65565600_65566271 | 9.79 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
1557 |
0.45 |
chr5_26904124_26905425 | 9.73 |
Dpp6 |
dipeptidylpeptidase 6 |
79 |
0.98 |
chr7_62416059_62417205 | 9.64 |
Mkrn3 |
makorin, ring finger protein, 3 |
3507 |
0.2 |
chr17_52602081_52603198 | 9.60 |
Gm27217 |
predicted gene 27217 |
21 |
0.54 |
chr5_111421306_111422790 | 9.60 |
Gm43119 |
predicted gene 43119 |
1541 |
0.35 |
chr2_178141581_178143125 | 9.58 |
Phactr3 |
phosphatase and actin regulator 3 |
420 |
0.88 |
chr1_66176824_66177184 | 9.53 |
Map2 |
microtubule-associated protein 2 |
1454 |
0.52 |
chr2_97470615_97471412 | 9.46 |
Lrrc4c |
leucine rich repeat containing 4C |
2924 |
0.4 |
chr9_96731522_96733329 | 9.43 |
Zbtb38 |
zinc finger and BTB domain containing 38 |
244 |
0.91 |
chr18_43686487_43688415 | 9.43 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
174 |
0.96 |
chr13_54874116_54875277 | 9.42 |
Gm29431 |
predicted gene 29431 |
12774 |
0.13 |
chr15_91017138_91018295 | 9.41 |
Kif21a |
kinesin family member 21A |
32102 |
0.16 |
chr3_114904046_114905354 | 9.40 |
Olfm3 |
olfactomedin 3 |
65 |
0.98 |
chr10_92163758_92164191 | 9.40 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
692 |
0.72 |
chr4_134470669_134471383 | 9.37 |
Stmn1 |
stathmin 1 |
1284 |
0.28 |
chr12_117153278_117156362 | 9.35 |
Gm10421 |
predicted gene 10421 |
3169 |
0.37 |
chr1_25228097_25229399 | 9.29 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
78 |
0.96 |
chr1_6729327_6730832 | 9.22 |
St18 |
suppression of tumorigenicity 18 |
9 |
0.99 |
chr5_112228060_112229152 | 9.22 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
35 |
0.96 |
chr16_77645925_77646470 | 9.21 |
Mir125b-2 |
microRNA 125b-2 |
76 |
0.58 |
chr3_88213113_88214199 | 9.19 |
Gm3764 |
predicted gene 3764 |
829 |
0.3 |
chr6_144202688_144204608 | 9.19 |
Sox5 |
SRY (sex determining region Y)-box 5 |
409 |
0.92 |
chr6_28828230_28829085 | 9.18 |
Lrrc4 |
leucine rich repeat containing 4 |
1688 |
0.37 |
chr10_36509078_36510052 | 9.17 |
Hs3st5 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 5 |
2158 |
0.44 |
chr4_110285468_110287125 | 9.14 |
Elavl4 |
ELAV like RNA binding protein 4 |
320 |
0.94 |
chr4_9270926_9271667 | 9.11 |
Clvs1 |
clavesin 1 |
159 |
0.96 |
chr1_194623571_194625393 | 9.07 |
Plxna2 |
plexin A2 |
4657 |
0.21 |
chr13_42709652_42710400 | 9.06 |
Phactr1 |
phosphatase and actin regulator 1 |
445 |
0.88 |
chr13_83717521_83718816 | 9.04 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
3213 |
0.17 |
chr1_77502484_77503419 | 9.03 |
Mir6352 |
microRNA 6352 |
6183 |
0.2 |
chr2_105680581_105683424 | 9.02 |
Pax6 |
paired box 6 |
290 |
0.89 |
chr3_89763591_89764832 | 8.95 |
Chrnb2 |
cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal) |
397 |
0.76 |
chr13_99446279_99447668 | 8.95 |
Map1b |
microtubule-associated protein 1B |
647 |
0.72 |
chr10_80298461_80300404 | 8.94 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
341 |
0.69 |
chr1_89073111_89073681 | 8.92 |
Sh3bp4 |
SH3-domain binding protein 4 |
2943 |
0.25 |
chr18_23038815_23040349 | 8.91 |
Nol4 |
nucleolar protein 4 |
496 |
0.88 |
chr11_104232729_104233170 | 8.90 |
Mapt |
microtubule-associated protein tau |
1365 |
0.36 |
chr9_106147912_106149765 | 8.89 |
D030055H07Rik |
RIKEN cDNA D030055H07 gene |
151 |
0.9 |
chr12_119235620_119236481 | 8.88 |
Itgb8 |
integrin beta 8 |
2720 |
0.31 |
chr7_144175485_144176434 | 8.82 |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
430 |
0.88 |
chr1_6760592_6761327 | 8.81 |
St18 |
suppression of tumorigenicity 18 |
23384 |
0.23 |
chr1_42686011_42687379 | 8.76 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
6398 |
0.14 |
chr14_29718651_29719941 | 8.68 |
Cacna2d3 |
calcium channel, voltage-dependent, alpha2/delta subunit 3 |
2499 |
0.26 |
chr8_106336310_106337932 | 8.67 |
Smpd3 |
sphingomyelin phosphodiesterase 3, neutral |
867 |
0.61 |
chr4_102761968_102762422 | 8.61 |
Sgip1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
1670 |
0.44 |
chr14_108910678_108911967 | 8.60 |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
2836 |
0.42 |
chr18_69348752_69349282 | 8.58 |
Tcf4 |
transcription factor 4 |
73 |
0.98 |
chr2_158609356_158610186 | 8.57 |
Gm14204 |
predicted gene 14204 |
819 |
0.36 |
chr8_45507516_45508498 | 8.50 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
89 |
0.97 |
chr5_106453173_106456366 | 8.48 |
Barhl2 |
BarH like homeobox 2 |
3397 |
0.22 |
chr7_99271595_99272046 | 8.47 |
Map6 |
microtubule-associated protein 6 |
2688 |
0.18 |
chr1_78190727_78191957 | 8.45 |
Pax3 |
paired box 3 |
5496 |
0.25 |
chr3_34656299_34657721 | 8.44 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
974 |
0.4 |
chr12_69907745_69908880 | 8.43 |
Atl1 |
atlastin GTPase 1 |
580 |
0.65 |
chr4_116405618_116406369 | 8.41 |
Mast2 |
microtubule associated serine/threonine kinase 2 |
7 |
0.98 |
chr1_42689823_42691041 | 8.41 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
2661 |
0.19 |
chr1_172485277_172486996 | 8.41 |
Igsf9 |
immunoglobulin superfamily, member 9 |
3822 |
0.12 |
chr2_6884711_6884884 | 8.34 |
Celf2 |
CUGBP, Elav-like family member 2 |
95 |
0.88 |
chr9_96729464_96730774 | 8.33 |
Zbtb38 |
zinc finger and BTB domain containing 38 |
1083 |
0.47 |
chr7_24485614_24487418 | 8.27 |
Cadm4 |
cell adhesion molecule 4 |
4493 |
0.1 |
chr5_102071739_102072402 | 8.24 |
Gm29707 |
predicted gene, 29707 |
1220 |
0.4 |
chr18_81165961_81166641 | 8.23 |
4930594M17Rik |
RIKEN cDNA 4930594M17 gene |
69765 |
0.09 |
chr13_78196283_78196791 | 8.23 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
164 |
0.91 |
chr14_122459815_122460898 | 8.22 |
Zic5 |
zinc finger protein of the cerebellum 5 |
335 |
0.81 |
chr13_34125172_34126139 | 8.15 |
Tubb2b |
tubulin, beta 2B class IIB |
4699 |
0.12 |
chr16_77787990_77788627 | 8.13 |
Gm17333 |
predicted gene, 17333 |
58296 |
0.11 |
chr12_105453821_105454975 | 8.11 |
D430019H16Rik |
RIKEN cDNA D430019H16 gene |
542 |
0.76 |
chr16_77594640_77595970 | 8.04 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
403 |
0.71 |
chr8_14382368_14383445 | 8.03 |
Dlgap2 |
DLG associated protein 2 |
910 |
0.66 |
chr14_122481884_122483266 | 8.02 |
Zic2 |
zinc finger protein of the cerebellum 2 |
4475 |
0.12 |
chr13_55484574_55485692 | 8.00 |
Dbn1 |
drebrin 1 |
1164 |
0.26 |
chr12_11880981_11881577 | 8.00 |
Tubb2a-ps2 |
tubulin, beta 2a, pseudogene 2 |
1384 |
0.49 |
chr3_84215699_84216651 | 7.99 |
Trim2 |
tripartite motif-containing 2 |
3337 |
0.29 |
chr8_8656555_8657725 | 7.98 |
Efnb2 |
ephrin B2 |
4099 |
0.11 |
chr5_131534533_131535200 | 7.98 |
Auts2 |
autism susceptibility candidate 2 |
469 |
0.81 |
chr9_102352095_102352639 | 7.93 |
Ephb1 |
Eph receptor B1 |
2326 |
0.28 |
chr4_82492692_82493928 | 7.93 |
Nfib |
nuclear factor I/B |
6006 |
0.22 |
chr7_91090740_91091963 | 7.92 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
623 |
0.71 |
chr18_25750468_25751272 | 7.91 |
Celf4 |
CUGBP, Elav-like family member 4 |
1822 |
0.41 |
chr2_74713881_74716227 | 7.89 |
Hoxd3os1 |
homeobox D3, opposite strand 1 |
942 |
0.23 |
chr18_35212708_35213458 | 7.87 |
Ctnna1 |
catenin (cadherin associated protein), alpha 1 |
1847 |
0.28 |
chr3_88530048_88530199 | 7.87 |
Mex3a |
mex3 RNA binding family member A |
2272 |
0.12 |
chr13_44842150_44842855 | 7.83 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
1719 |
0.39 |
chr9_41376046_41377501 | 7.82 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
212 |
0.93 |
chr5_66336775_66338292 | 7.78 |
Apbb2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
50 |
0.96 |
chr17_17402413_17403374 | 7.77 |
Lix1 |
limb and CNS expressed 1 |
221 |
0.91 |
chr9_41326803_41329121 | 7.77 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
676 |
0.69 |
chr9_110051810_110053856 | 7.76 |
Map4 |
microtubule-associated protein 4 |
781 |
0.54 |
chr6_13835523_13837039 | 7.75 |
Gpr85 |
G protein-coupled receptor 85 |
960 |
0.59 |
chr3_88211471_88212561 | 7.74 |
Gm3764 |
predicted gene 3764 |
2469 |
0.11 |
chr3_17791717_17791961 | 7.74 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1882 |
0.32 |
chr4_42951254_42951979 | 7.72 |
Dnajb5 |
DnaJ heat shock protein family (Hsp40) member B5 |
1176 |
0.34 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.9 | 32.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
8.3 | 74.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
6.5 | 19.4 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
6.4 | 25.5 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
5.7 | 17.1 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
5.4 | 21.8 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
5.4 | 5.4 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
5.3 | 16.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
5.2 | 15.6 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
5.2 | 15.6 | GO:0046684 | response to pyrethroid(GO:0046684) |
5.2 | 25.9 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
5.1 | 30.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
5.0 | 15.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
4.9 | 19.6 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
4.9 | 9.8 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
4.8 | 19.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
4.7 | 14.2 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
4.7 | 56.1 | GO:0071625 | vocalization behavior(GO:0071625) |
4.3 | 13.0 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
4.2 | 29.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
4.1 | 16.5 | GO:0030035 | microspike assembly(GO:0030035) |
4.1 | 8.2 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
4.1 | 45.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
4.0 | 15.9 | GO:0060174 | limb bud formation(GO:0060174) |
3.9 | 15.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
3.8 | 30.2 | GO:0021860 | pyramidal neuron development(GO:0021860) |
3.8 | 15.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
3.7 | 7.5 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
3.7 | 14.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
3.7 | 11.0 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
3.5 | 10.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
3.5 | 76.0 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
3.4 | 24.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
3.4 | 6.8 | GO:0060594 | mammary gland specification(GO:0060594) |
3.3 | 26.5 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
3.3 | 6.6 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
3.2 | 12.7 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
3.2 | 9.5 | GO:0021586 | pons maturation(GO:0021586) |
3.1 | 15.6 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
3.1 | 3.1 | GO:0097491 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
3.1 | 6.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
3.0 | 9.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
3.0 | 9.0 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
3.0 | 47.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
2.9 | 11.4 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
2.8 | 13.9 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
2.8 | 2.8 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
2.7 | 16.5 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
2.7 | 16.4 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
2.5 | 5.1 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
2.5 | 5.1 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
2.4 | 9.8 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
2.4 | 7.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
2.4 | 4.8 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.4 | 14.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
2.4 | 4.7 | GO:0060166 | olfactory pit development(GO:0060166) |
2.4 | 9.4 | GO:0007412 | axon target recognition(GO:0007412) |
2.4 | 4.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.3 | 2.3 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
2.3 | 16.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
2.2 | 8.9 | GO:0006538 | glutamate catabolic process(GO:0006538) |
2.2 | 8.8 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
2.2 | 10.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
2.1 | 6.4 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
2.1 | 8.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
2.1 | 6.2 | GO:0010046 | response to mycotoxin(GO:0010046) |
2.1 | 2.1 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
2.0 | 10.2 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
2.0 | 2.0 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
2.0 | 6.0 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
2.0 | 6.0 | GO:0097503 | sialylation(GO:0097503) |
2.0 | 21.8 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
2.0 | 15.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
2.0 | 3.9 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
1.9 | 1.9 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.9 | 17.1 | GO:0045176 | apical protein localization(GO:0045176) |
1.9 | 5.7 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
1.9 | 3.8 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.9 | 3.7 | GO:0021557 | oculomotor nerve development(GO:0021557) |
1.9 | 9.3 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
1.9 | 5.6 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.8 | 5.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.8 | 14.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
1.8 | 3.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.8 | 3.6 | GO:0007413 | axonal fasciculation(GO:0007413) |
1.8 | 9.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.8 | 5.4 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.8 | 7.2 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
1.8 | 7.1 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
1.8 | 23.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
1.8 | 1.8 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
1.8 | 8.8 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
1.8 | 1.8 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.7 | 1.7 | GO:0008038 | neuron recognition(GO:0008038) |
1.7 | 5.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.7 | 12.1 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
1.7 | 3.4 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
1.7 | 6.9 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.7 | 5.1 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
1.7 | 5.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.7 | 6.8 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
1.7 | 11.9 | GO:0097264 | self proteolysis(GO:0097264) |
1.7 | 5.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.7 | 8.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
1.7 | 3.4 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
1.7 | 10.0 | GO:0048840 | otolith development(GO:0048840) |
1.7 | 21.7 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.7 | 5.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
1.7 | 3.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.6 | 8.2 | GO:0098597 | observational learning(GO:0098597) |
1.6 | 1.6 | GO:0031223 | auditory behavior(GO:0031223) |
1.6 | 4.7 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.6 | 14.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
1.6 | 7.8 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.6 | 1.6 | GO:0061743 | motor learning(GO:0061743) |
1.6 | 6.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.5 | 20.1 | GO:0060074 | synapse maturation(GO:0060074) |
1.5 | 12.4 | GO:0050957 | equilibrioception(GO:0050957) |
1.5 | 4.6 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
1.5 | 1.5 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
1.5 | 9.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.5 | 4.5 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.5 | 10.4 | GO:0060346 | bone trabecula formation(GO:0060346) |
1.5 | 4.5 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
1.5 | 17.7 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.5 | 4.4 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.5 | 7.4 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.5 | 4.4 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
1.5 | 7.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
1.4 | 2.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.4 | 1.4 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
1.4 | 2.9 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
1.4 | 7.1 | GO:0072017 | distal tubule development(GO:0072017) |
1.4 | 1.4 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
1.4 | 21.2 | GO:0007019 | microtubule depolymerization(GO:0007019) |
1.4 | 2.8 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
1.4 | 5.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.4 | 4.2 | GO:0030070 | insulin processing(GO:0030070) |
1.4 | 71.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.4 | 51.1 | GO:0021954 | central nervous system neuron development(GO:0021954) |
1.4 | 23.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.4 | 2.8 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.4 | 5.5 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.4 | 8.2 | GO:0007614 | short-term memory(GO:0007614) |
1.4 | 8.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.3 | 5.3 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
1.3 | 25.2 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
1.3 | 2.6 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.3 | 2.6 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.3 | 2.6 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.3 | 2.6 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
1.3 | 2.6 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
1.3 | 2.6 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
1.3 | 2.6 | GO:0030916 | otic vesicle formation(GO:0030916) |
1.3 | 3.8 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
1.3 | 5.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.3 | 148.5 | GO:0097485 | neuron projection guidance(GO:0097485) |
1.3 | 19.0 | GO:0001964 | startle response(GO:0001964) |
1.3 | 13.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.3 | 1.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
1.2 | 3.7 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.2 | 3.7 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
1.2 | 7.3 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.2 | 6.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.2 | 1.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.2 | 4.8 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.2 | 2.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
1.2 | 3.6 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
1.2 | 3.6 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.2 | 3.5 | GO:0060437 | lung growth(GO:0060437) |
1.2 | 28.3 | GO:0007416 | synapse assembly(GO:0007416) |
1.2 | 5.9 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
1.2 | 5.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.2 | 10.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
1.1 | 14.9 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
1.1 | 2.3 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
1.1 | 2.3 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
1.1 | 3.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.1 | 1.1 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
1.1 | 5.6 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
1.1 | 2.2 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.1 | 3.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.1 | 1.1 | GO:0035973 | aggrephagy(GO:0035973) |
1.1 | 13.2 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
1.1 | 6.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.1 | 1.1 | GO:0021871 | forebrain regionalization(GO:0021871) |
1.1 | 8.7 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
1.1 | 2.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.1 | 13.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.1 | 4.2 | GO:0014028 | notochord formation(GO:0014028) |
1.1 | 5.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
1.0 | 1.0 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
1.0 | 1.0 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.0 | 2.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
1.0 | 1.0 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
1.0 | 5.0 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
1.0 | 1.0 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
1.0 | 1.0 | GO:0032898 | neurotrophin production(GO:0032898) |
1.0 | 1.0 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
1.0 | 3.9 | GO:0021794 | thalamus development(GO:0021794) |
1.0 | 6.7 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
1.0 | 7.7 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.9 | 27.0 | GO:0019228 | neuronal action potential(GO:0019228) |
0.9 | 3.7 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.9 | 1.9 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.9 | 1.8 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.9 | 1.8 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.9 | 56.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.9 | 3.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.9 | 6.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.9 | 17.0 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.9 | 0.9 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.9 | 4.4 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.9 | 0.9 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.9 | 0.9 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.9 | 0.9 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.9 | 2.6 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.9 | 3.4 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.9 | 3.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.9 | 6.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.8 | 1.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.8 | 0.8 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.8 | 3.4 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.8 | 5.0 | GO:0060179 | male mating behavior(GO:0060179) |
0.8 | 3.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.8 | 3.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.8 | 3.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.8 | 5.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.8 | 2.4 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.8 | 6.4 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.8 | 3.2 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.8 | 1.6 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.8 | 19.8 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.8 | 2.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.8 | 1.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.8 | 0.8 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.8 | 0.8 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.8 | 3.9 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.8 | 2.3 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.8 | 0.8 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.8 | 4.6 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.8 | 2.3 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.8 | 2.3 | GO:0015744 | succinate transport(GO:0015744) |
0.8 | 1.5 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.8 | 3.8 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.8 | 0.8 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.7 | 1.5 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.7 | 11.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.7 | 1.5 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.7 | 0.7 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.7 | 1.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.7 | 1.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.7 | 1.5 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.7 | 0.7 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.7 | 5.8 | GO:0030828 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.7 | 2.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.7 | 2.2 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.7 | 2.2 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.7 | 1.4 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.7 | 2.2 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.7 | 2.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.7 | 6.4 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.7 | 2.9 | GO:0030091 | protein repair(GO:0030091) |
0.7 | 2.1 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.7 | 1.4 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.7 | 1.4 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.7 | 0.7 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.7 | 3.4 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.7 | 1.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.7 | 4.8 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.7 | 0.7 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.7 | 2.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.7 | 2.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.7 | 0.7 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.7 | 1.3 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.7 | 5.9 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.7 | 14.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.6 | 3.2 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.6 | 0.6 | GO:0032536 | regulation of cell projection size(GO:0032536) |
0.6 | 1.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.6 | 1.9 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.6 | 4.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.6 | 4.4 | GO:0034776 | response to histamine(GO:0034776) |
0.6 | 1.3 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.6 | 1.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.6 | 2.5 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.6 | 1.9 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.6 | 0.6 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.6 | 0.6 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.6 | 17.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.6 | 4.4 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.6 | 9.4 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.6 | 3.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.6 | 3.7 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.6 | 1.9 | GO:0008347 | glial cell migration(GO:0008347) |
0.6 | 0.6 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.6 | 2.4 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.6 | 1.8 | GO:0032439 | endosome localization(GO:0032439) |
0.6 | 1.8 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.6 | 1.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.6 | 1.2 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.6 | 1.2 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.6 | 4.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.6 | 3.0 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.6 | 6.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.6 | 2.4 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.6 | 6.5 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.6 | 5.3 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.6 | 7.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.6 | 1.8 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.6 | 2.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.6 | 0.6 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.6 | 0.6 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.6 | 3.5 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.6 | 1.8 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.6 | 1.2 | GO:0033483 | gas homeostasis(GO:0033483) |
0.6 | 0.6 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.6 | 3.5 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.6 | 3.5 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.6 | 1.7 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.6 | 7.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.6 | 1.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.6 | 1.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.6 | 0.6 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.6 | 9.0 | GO:0021766 | hippocampus development(GO:0021766) |
0.6 | 0.6 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.6 | 2.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.6 | 1.1 | GO:1905214 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
0.6 | 2.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.5 | 2.7 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.5 | 3.8 | GO:0060539 | diaphragm development(GO:0060539) |
0.5 | 4.3 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.5 | 6.4 | GO:0051905 | establishment of pigment granule localization(GO:0051905) |
0.5 | 2.7 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.5 | 1.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.5 | 1.1 | GO:0061055 | myotome development(GO:0061055) |
0.5 | 1.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.5 | 1.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.5 | 3.2 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.5 | 0.5 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.5 | 1.0 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.5 | 0.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.5 | 1.0 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.5 | 2.1 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.5 | 5.2 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.5 | 25.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.5 | 2.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.5 | 2.1 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.5 | 2.6 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.5 | 2.0 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.5 | 0.5 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.5 | 14.2 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.5 | 1.0 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.5 | 1.5 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.5 | 2.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.5 | 2.0 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.5 | 1.0 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.5 | 2.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.5 | 2.0 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.5 | 1.5 | GO:0034214 | protein hexamerization(GO:0034214) |
0.5 | 1.5 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.5 | 5.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.5 | 0.5 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.5 | 1.4 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.5 | 1.9 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.5 | 1.4 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.5 | 1.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.5 | 5.8 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.5 | 1.4 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.5 | 1.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.5 | 2.8 | GO:0015816 | glycine transport(GO:0015816) |
0.5 | 5.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.5 | 1.4 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.5 | 1.4 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.5 | 5.1 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.5 | 0.9 | GO:0006868 | glutamine transport(GO:0006868) |
0.5 | 0.5 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.5 | 0.9 | GO:0021854 | hypothalamus development(GO:0021854) |
0.5 | 3.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.5 | 1.8 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.5 | 1.4 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.5 | 3.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 0.9 | GO:0051182 | coenzyme transport(GO:0051182) |
0.5 | 26.2 | GO:0007612 | learning(GO:0007612) |
0.5 | 2.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.5 | 1.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.5 | 0.9 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.4 | 0.9 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.4 | 0.9 | GO:2001138 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.4 | 1.3 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.4 | 0.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.4 | 1.8 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 1.3 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.4 | 0.4 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.4 | 1.3 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.4 | 2.6 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.4 | 0.4 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.4 | 1.7 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.4 | 1.7 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.4 | 1.7 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.4 | 0.9 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.4 | 0.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.4 | 0.4 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.4 | 1.7 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.4 | 2.9 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.4 | 2.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.4 | 1.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.4 | 0.8 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.4 | 2.9 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.4 | 0.8 | GO:0008354 | germ cell migration(GO:0008354) |
0.4 | 0.4 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.4 | 2.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.4 | 0.4 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.4 | 2.4 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.4 | 0.8 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.4 | 2.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.4 | 2.8 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.4 | 1.2 | GO:0015755 | fructose transport(GO:0015755) |
0.4 | 1.2 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.4 | 2.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.4 | 14.3 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.4 | 0.4 | GO:0043465 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.4 | 2.0 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.4 | 0.8 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.4 | 1.6 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.4 | 0.8 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.4 | 2.7 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.4 | 0.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 0.8 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.4 | 3.8 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.4 | 1.1 | GO:0086015 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.4 | 0.4 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.4 | 4.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.4 | 1.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.4 | 0.7 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.4 | 0.7 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.4 | 1.1 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.4 | 0.4 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.4 | 0.4 | GO:0071288 | cellular response to copper ion(GO:0071280) cellular response to mercury ion(GO:0071288) |
0.4 | 0.4 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.4 | 1.8 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.4 | 0.4 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.3 | 1.7 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.3 | 1.0 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 0.3 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.3 | 1.0 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 0.7 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.3 | 0.7 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.3 | 0.7 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.3 | 3.3 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.3 | 1.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.3 | 2.9 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.3 | 0.6 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.3 | 0.6 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.3 | 1.3 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.3 | 2.8 | GO:0050905 | neuromuscular process(GO:0050905) |
0.3 | 0.9 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.3 | 1.3 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.3 | 0.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.3 | 0.3 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.3 | 4.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.3 | 1.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.3 | 0.9 | GO:0003140 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) |
0.3 | 1.8 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.3 | 1.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 0.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.3 | 2.1 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.3 | 1.8 | GO:0007616 | long-term memory(GO:0007616) |
0.3 | 0.3 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.3 | 0.6 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.3 | 0.6 | GO:0015808 | L-alanine transport(GO:0015808) |
0.3 | 0.9 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.3 | 1.5 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.3 | 0.3 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.3 | 1.2 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.3 | 0.3 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.3 | 0.6 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.3 | 1.7 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.3 | 0.9 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.3 | 0.9 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.3 | 0.3 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.3 | 1.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.3 | 1.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 0.3 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.3 | 0.8 | GO:0042161 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.3 | 1.9 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.3 | 0.6 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.3 | 0.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.3 | 1.4 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.3 | 0.8 | GO:0019695 | choline metabolic process(GO:0019695) |
0.3 | 0.8 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.3 | 0.5 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.3 | 0.8 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.3 | 0.8 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.3 | 2.4 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.3 | 1.3 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.3 | 0.3 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.3 | 0.5 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.3 | 0.8 | GO:0015888 | thiamine transport(GO:0015888) |
0.3 | 0.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 1.6 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.3 | 3.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.3 | 2.1 | GO:0098868 | bone growth(GO:0098868) |
0.3 | 1.3 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.3 | 1.0 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.3 | 1.0 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.3 | 1.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 0.5 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.3 | 0.8 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.3 | 0.5 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.3 | 0.8 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.3 | 3.0 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.2 | 0.2 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.2 | 0.2 | GO:0030421 | defecation(GO:0030421) |
0.2 | 0.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 1.7 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.2 | 0.7 | GO:0015867 | ATP transport(GO:0015867) |
0.2 | 0.2 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.2 | 0.2 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.2 | 0.5 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 0.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 0.9 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.2 | 0.7 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 1.2 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.2 | 0.5 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 0.7 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.2 | 0.5 | GO:0070268 | cornification(GO:0070268) |
0.2 | 0.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 0.4 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 2.0 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 1.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.2 | 0.2 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.2 | 2.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.4 | GO:0002339 | B cell selection(GO:0002339) |
0.2 | 3.2 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.2 | 0.4 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 0.8 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 1.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.2 | 0.4 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.2 | 0.6 | GO:0061005 | cell differentiation involved in kidney development(GO:0061005) |
0.2 | 1.7 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.2 | 0.8 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 1.0 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.2 | 0.8 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.2 | 0.8 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 1.0 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.2 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
0.2 | 0.6 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 1.8 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 6.7 | GO:0001764 | neuron migration(GO:0001764) |
0.2 | 0.6 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 0.6 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.2 | 1.4 | GO:0002063 | chondrocyte development(GO:0002063) |
0.2 | 0.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.2 | 0.2 | GO:0042048 | olfactory behavior(GO:0042048) |
0.2 | 0.4 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.2 | 0.2 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 0.6 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 3.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 1.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 0.6 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 0.2 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.2 | 12.0 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.2 | 2.2 | GO:0046931 | pore complex assembly(GO:0046931) |
0.2 | 0.6 | GO:0071435 | potassium ion export(GO:0071435) |
0.2 | 1.9 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 0.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 2.2 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.2 | 1.1 | GO:0001967 | suckling behavior(GO:0001967) |
0.2 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 0.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.2 | 0.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.2 | GO:2000054 | response to parathyroid hormone(GO:0071107) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.2 | 0.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.5 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 0.4 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.2 | 0.2 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.2 | 0.5 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.2 | 0.2 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.2 | 0.5 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.2 | 1.0 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 0.3 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.2 | 0.3 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.2 | 0.9 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 2.0 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.2 | 3.6 | GO:0060325 | face morphogenesis(GO:0060325) |
0.2 | 0.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 1.0 | GO:0051231 | spindle elongation(GO:0051231) |
0.2 | 0.2 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.2 | 0.5 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.2 | 0.3 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.2 | 0.2 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 2.8 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.2 | 0.5 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.2 | 0.8 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 0.7 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.2 | 0.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.6 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.2 | 0.6 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 0.8 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 2.9 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 0.5 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.2 | 0.3 | GO:0097061 | dendritic spine organization(GO:0097061) |
0.2 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 0.5 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 0.2 | GO:0015824 | proline transport(GO:0015824) |
0.2 | 0.3 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.2 | 0.9 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.2 | 0.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 2.0 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.2 | 0.2 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 0.3 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.7 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.3 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.3 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.4 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
0.1 | 10.4 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.1 | 1.6 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.1 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.1 | 0.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.3 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 | 0.8 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.1 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 0.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.1 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.1 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.4 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.4 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 8.4 | GO:0007409 | axonogenesis(GO:0007409) |
0.1 | 2.7 | GO:0021543 | pallium development(GO:0021543) |
0.1 | 0.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.1 | GO:0043307 | eosinophil activation(GO:0043307) |
0.1 | 0.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 1.0 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 2.2 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.1 | 0.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 1.2 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.4 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.4 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.1 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.1 | 1.7 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 1.1 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.1 | 0.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 1.3 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.5 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.1 | 2.5 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.4 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.2 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.2 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.2 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.1 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.3 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.1 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 0.2 | GO:0060384 | innervation(GO:0060384) |
0.1 | 0.2 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 2.0 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 1.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.4 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.6 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.3 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.1 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.1 | 0.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 3.2 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.5 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 0.8 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.9 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 1.0 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 0.1 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.8 | GO:0032835 | glomerulus development(GO:0032835) |
0.1 | 0.2 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.3 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.1 | 0.8 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.3 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.1 | 0.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.3 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.1 | 0.3 | GO:0070589 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 2.1 | GO:0050808 | synapse organization(GO:0050808) |
0.1 | 0.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 1.8 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 0.2 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 0.1 | GO:0060359 | response to ammonium ion(GO:0060359) |
0.1 | 0.2 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.1 | GO:0001975 | response to amphetamine(GO:0001975) |
0.1 | 1.2 | GO:0035082 | axoneme assembly(GO:0035082) |
0.1 | 0.1 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.1 | 0.4 | GO:0060004 | reflex(GO:0060004) |
0.1 | 0.1 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.1 | 0.8 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.2 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 0.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.1 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.1 | 0.1 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.1 | 0.3 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.1 | 0.2 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.1 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.1 | 0.1 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.1 | GO:0002739 | regulation of cytokine secretion involved in immune response(GO:0002739) positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.1 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.3 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.1 | 4.0 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) |
0.1 | 0.5 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.7 | GO:0061245 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.1 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.1 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.1 | 0.6 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.2 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.6 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.3 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.1 | 0.1 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 0.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.1 | 0.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.1 | 0.1 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.1 | 0.1 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.0 | 0.0 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.0 | 1.1 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.0 | 1.4 | GO:0031345 | negative regulation of cell projection organization(GO:0031345) |
0.0 | 0.2 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.0 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.0 | 0.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.0 | 0.1 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.0 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.0 | 0.5 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.1 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
0.0 | 0.0 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.0 | 0.0 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.0 | 0.1 | GO:0048263 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.0 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.0 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.0 | 0.2 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.0 | 0.0 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.0 | 0.0 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.1 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.0 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.0 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) |
0.0 | 0.0 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.0 | 0.0 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.0 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.0 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.0 | 0.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0015819 | lysine transport(GO:0015819) |
0.0 | 0.0 | GO:0001660 | fever generation(GO:0001660) |
0.0 | 0.3 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.0 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 0.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.9 | 17.8 | GO:0097451 | glial limiting end-foot(GO:0097451) |
4.5 | 26.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
4.2 | 25.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
4.1 | 49.1 | GO:0043194 | axon initial segment(GO:0043194) |
3.9 | 35.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
3.9 | 30.9 | GO:0071437 | invadopodium(GO:0071437) |
3.5 | 28.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
3.0 | 83.7 | GO:0044295 | axonal growth cone(GO:0044295) |
3.0 | 17.9 | GO:0032584 | growth cone membrane(GO:0032584) |
2.9 | 26.0 | GO:0005883 | neurofilament(GO:0005883) |
2.8 | 8.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
2.7 | 21.7 | GO:0043083 | synaptic cleft(GO:0043083) |
2.6 | 25.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
2.5 | 7.4 | GO:0072534 | perineuronal net(GO:0072534) |
2.2 | 10.8 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
2.1 | 14.4 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.9 | 36.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.9 | 5.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.7 | 45.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.7 | 5.0 | GO:0033010 | paranodal junction(GO:0033010) |
1.7 | 49.9 | GO:0031941 | filamentous actin(GO:0031941) |
1.6 | 3.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.6 | 50.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
1.6 | 58.9 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
1.6 | 11.1 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.6 | 20.2 | GO:0043196 | varicosity(GO:0043196) |
1.5 | 17.0 | GO:0035102 | PRC1 complex(GO:0035102) |
1.5 | 8.9 | GO:0016342 | catenin complex(GO:0016342) |
1.5 | 5.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.4 | 11.5 | GO:0030673 | axolemma(GO:0030673) |
1.4 | 12.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
1.4 | 4.1 | GO:0033268 | node of Ranvier(GO:0033268) |
1.4 | 42.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.3 | 17.9 | GO:0071565 | nBAF complex(GO:0071565) |
1.3 | 53.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.2 | 2.5 | GO:1990635 | proximal dendrite(GO:1990635) |
1.2 | 10.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.2 | 16.9 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.2 | 9.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.2 | 3.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.1 | 6.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
1.1 | 2.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
1.0 | 2.1 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
1.0 | 148.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.0 | 3.9 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.0 | 6.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.9 | 7.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.9 | 0.9 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.8 | 8.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.8 | 2.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.8 | 4.8 | GO:0070852 | cell body fiber(GO:0070852) |
0.8 | 0.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.8 | 3.8 | GO:0071547 | piP-body(GO:0071547) |
0.7 | 0.7 | GO:0035838 | growing cell tip(GO:0035838) |
0.7 | 2.9 | GO:0097449 | astrocyte projection(GO:0097449) |
0.7 | 36.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.7 | 1.4 | GO:0032280 | symmetric synapse(GO:0032280) |
0.7 | 1.4 | GO:0097441 | basilar dendrite(GO:0097441) |
0.7 | 4.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.7 | 50.5 | GO:0043204 | perikaryon(GO:0043204) |
0.6 | 1.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.6 | 9.0 | GO:0043205 | fibril(GO:0043205) |
0.6 | 0.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.6 | 10.0 | GO:0044298 | cell body membrane(GO:0044298) |
0.6 | 48.0 | GO:0030426 | growth cone(GO:0030426) |
0.6 | 1.8 | GO:0034706 | sodium channel complex(GO:0034706) |
0.6 | 3.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.6 | 21.8 | GO:0030175 | filopodium(GO:0030175) |
0.6 | 0.6 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.5 | 4.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.5 | 4.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.5 | 0.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.5 | 8.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.5 | 3.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 24.8 | GO:0043195 | terminal bouton(GO:0043195) |
0.5 | 2.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.5 | 8.0 | GO:0097060 | synaptic membrane(GO:0097060) |
0.5 | 5.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.5 | 4.0 | GO:0005869 | dynactin complex(GO:0005869) |
0.5 | 1.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.5 | 1.5 | GO:0043203 | axon hillock(GO:0043203) |
0.5 | 1.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.4 | 3.6 | GO:0001520 | outer dense fiber(GO:0001520) |
0.4 | 3.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.4 | 1.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.4 | 1.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.4 | 0.8 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.4 | 0.8 | GO:0033269 | internode region of axon(GO:0033269) |
0.4 | 2.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.4 | 1.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 1.2 | GO:0005745 | m-AAA complex(GO:0005745) |
0.4 | 1.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.4 | 4.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 2.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.4 | 1.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.4 | 1.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 2.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.4 | 1.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 1.4 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.3 | 1.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 5.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 1.6 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 68.5 | GO:0030425 | dendrite(GO:0030425) |
0.3 | 3.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 1.0 | GO:1990393 | 3M complex(GO:1990393) |
0.3 | 4.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 0.3 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.3 | 2.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 0.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.3 | 0.9 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 0.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 1.7 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.3 | 1.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 14.9 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.3 | 0.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.3 | 0.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.3 | 0.8 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.3 | 0.8 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.3 | 15.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 0.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 32.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 1.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 2.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 4.2 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 0.7 | GO:0042827 | platelet dense granule(GO:0042827) |
0.2 | 2.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 0.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 2.6 | GO:0031011 | Ino80 complex(GO:0031011) |
0.2 | 0.9 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 0.6 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 0.6 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 0.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 10.3 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.2 | 0.2 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.2 | 0.6 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 1.9 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.2 | 1.9 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 0.6 | GO:0000802 | transverse filament(GO:0000802) |
0.2 | 1.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 2.7 | GO:0043073 | male germ cell nucleus(GO:0001673) germ cell nucleus(GO:0043073) |
0.2 | 4.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 2.2 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 0.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 2.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 2.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 1.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 1.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 21.0 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.5 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.6 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.5 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 1.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.9 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 1.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.4 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 4.1 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.4 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.9 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.3 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 16.3 | GO:0043005 | neuron projection(GO:0043005) |
0.1 | 0.4 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.5 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.3 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 5.3 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.4 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.1 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 3.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.0 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.6 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.0 | GO:0071439 | clathrin complex(GO:0071439) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.8 | 53.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
11.5 | 57.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
5.4 | 16.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
5.0 | 15.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
4.9 | 14.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
4.7 | 18.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
4.0 | 20.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
3.9 | 11.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
3.5 | 31.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
3.5 | 20.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
3.5 | 10.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.4 | 23.8 | GO:0003680 | AT DNA binding(GO:0003680) |
3.3 | 26.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
3.1 | 43.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
3.0 | 38.6 | GO:0031005 | filamin binding(GO:0031005) |
2.9 | 14.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
2.9 | 34.6 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
2.6 | 10.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
2.6 | 5.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
2.5 | 14.8 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
2.4 | 7.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
2.4 | 14.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
2.3 | 2.3 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
2.2 | 8.9 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
2.2 | 6.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
2.1 | 4.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.1 | 10.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
2.0 | 18.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
2.0 | 6.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
2.0 | 6.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
2.0 | 8.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
2.0 | 30.0 | GO:0031402 | sodium ion binding(GO:0031402) |
2.0 | 2.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
2.0 | 7.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
2.0 | 11.8 | GO:0048495 | Roundabout binding(GO:0048495) |
1.9 | 5.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.9 | 9.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.9 | 14.9 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.8 | 11.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.8 | 5.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.8 | 1.8 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.8 | 9.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.8 | 41.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.8 | 10.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.8 | 5.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.7 | 8.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.7 | 6.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.7 | 6.6 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
1.6 | 6.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.6 | 3.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.6 | 8.0 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.5 | 10.4 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
1.5 | 4.4 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
1.5 | 5.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.4 | 15.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.4 | 4.3 | GO:0004946 | bombesin receptor activity(GO:0004946) |
1.4 | 6.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
1.4 | 10.9 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
1.4 | 4.1 | GO:0005119 | smoothened binding(GO:0005119) |
1.3 | 5.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.3 | 14.5 | GO:0005522 | profilin binding(GO:0005522) |
1.3 | 2.6 | GO:0097016 | L27 domain binding(GO:0097016) |
1.3 | 28.4 | GO:0052712 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.3 | 3.9 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.3 | 5.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
1.3 | 5.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.2 | 3.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.2 | 26.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.2 | 2.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.2 | 13.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.2 | 13.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.2 | 2.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.2 | 13.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
1.2 | 3.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
1.2 | 4.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.2 | 3.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.2 | 8.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.1 | 26.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.1 | 32.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
1.1 | 4.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.1 | 4.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
1.1 | 3.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
1.1 | 11.9 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.1 | 25.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.1 | 19.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
1.1 | 26.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
1.1 | 2.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
1.1 | 7.4 | GO:0043495 | protein anchor(GO:0043495) |
1.0 | 3.1 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
1.0 | 4.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.0 | 7.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.0 | 2.0 | GO:0035939 | microsatellite binding(GO:0035939) |
1.0 | 12.1 | GO:0035198 | miRNA binding(GO:0035198) |
1.0 | 10.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.0 | 6.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.0 | 11.8 | GO:0015026 | coreceptor activity(GO:0015026) |
1.0 | 7.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.0 | 3.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.0 | 1.0 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.0 | 17.2 | GO:0005112 | Notch binding(GO:0005112) |
0.9 | 33.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.9 | 18.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.9 | 4.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.9 | 4.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.9 | 4.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.9 | 3.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.9 | 8.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.9 | 2.7 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.9 | 4.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.9 | 10.5 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.9 | 7.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.9 | 0.9 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.8 | 22.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.8 | 13.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.8 | 12.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.8 | 14.9 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.8 | 0.8 | GO:0048030 | disaccharide binding(GO:0048030) |
0.8 | 23.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.8 | 2.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.8 | 8.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.8 | 0.8 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.8 | 21.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.8 | 2.3 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.8 | 2.3 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.8 | 0.8 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.8 | 28.1 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.8 | 2.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.7 | 1.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.7 | 2.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.7 | 5.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.7 | 0.7 | GO:0051378 | serotonin binding(GO:0051378) |
0.7 | 1.5 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.7 | 2.9 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.7 | 2.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.7 | 16.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.7 | 6.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.7 | 4.0 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.7 | 14.6 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.7 | 9.9 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.6 | 14.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.6 | 1.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.6 | 1.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.6 | 1.8 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.6 | 16.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.6 | 1.8 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.6 | 14.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.6 | 1.8 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.6 | 1.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.6 | 2.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.6 | 1.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.6 | 2.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.6 | 8.6 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.6 | 0.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.6 | 13.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.6 | 3.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.5 | 1.6 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.5 | 5.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.5 | 4.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.5 | 2.7 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.5 | 11.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.5 | 8.5 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.5 | 2.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.5 | 4.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.5 | 1.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.5 | 6.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.5 | 8.2 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.5 | 4.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.5 | 3.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 5.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 2.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.5 | 10.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.5 | 6.7 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.5 | 2.8 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.5 | 3.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.5 | 5.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.5 | 0.9 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.5 | 6.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.5 | 2.3 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 1.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.5 | 2.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.5 | 5.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.4 | 0.9 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 5.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.4 | 0.9 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.4 | 1.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 1.3 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.4 | 1.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 1.3 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.4 | 1.7 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.4 | 2.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.4 | 1.3 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.4 | 88.4 | GO:0015631 | tubulin binding(GO:0015631) |
0.4 | 0.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.4 | 1.3 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.4 | 13.6 | GO:0005262 | calcium channel activity(GO:0005262) |
0.4 | 2.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.4 | 1.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.4 | 1.6 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.4 | 1.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.4 | 10.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.4 | 1.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.4 | 2.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.4 | 1.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.4 | 2.4 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.4 | 5.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.4 | 4.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.4 | 1.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.4 | 1.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.4 | 7.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.4 | 1.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 5.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.4 | 4.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.4 | 0.4 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.4 | 1.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 4.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.3 | 6.6 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.3 | 2.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.3 | 1.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.3 | 2.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.3 | 1.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.3 | 3.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 3.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 4.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.3 | 1.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.3 | 1.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 0.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 0.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.3 | 3.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.3 | 0.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.3 | 1.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.3 | 1.2 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.3 | 4.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 6.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.3 | 3.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 1.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 1.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 1.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.3 | 5.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.3 | 2.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 0.9 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.3 | 2.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.3 | 5.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.3 | 1.4 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.3 | 0.8 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.3 | 0.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 1.4 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.3 | 3.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 1.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 1.9 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.3 | 2.4 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 2.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.3 | 0.8 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.3 | 0.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 3.8 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.3 | 9.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.3 | 15.2 | GO:0005261 | cation channel activity(GO:0005261) |
0.3 | 0.8 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.3 | 17.3 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.2 | 1.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 15.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 0.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 1.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 1.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 0.7 | GO:0018557 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.2 | 0.2 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.2 | 2.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 2.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 3.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 2.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 0.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 0.7 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 1.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 0.7 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 0.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 43.6 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.2 | 1.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 0.6 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.2 | 0.6 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.2 | 3.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 1.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 0.6 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 0.4 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.2 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 0.8 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 1.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.2 | 2.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.2 | 2.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 1.8 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 0.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 0.2 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.2 | 0.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 0.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 1.4 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.2 | 0.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 1.4 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 1.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 0.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 1.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 5.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.2 | 1.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.2 | 0.9 | GO:0035242 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 0.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 1.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 2.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 2.3 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 1.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.8 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 1.1 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 1.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 1.4 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.3 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.1 | 0.1 | GO:0034862 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 1.9 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.4 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.4 | GO:0043918 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.1 | 51.8 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.5 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.1 | 2.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.8 | GO:0070694 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.1 | 0.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.6 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.1 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 6.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.4 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 1.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.3 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 2.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.7 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.7 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.5 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.1 | 0.5 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.3 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 1.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 1.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.8 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.3 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 1.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 1.6 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.1 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.1 | 0.3 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 0.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.2 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.0 | 0.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 1.6 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.3 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 51.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
1.4 | 22.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.1 | 15.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.1 | 25.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.1 | 31.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.0 | 24.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.9 | 12.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.8 | 1.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.8 | 23.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.8 | 12.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.8 | 7.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.7 | 25.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.7 | 22.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.7 | 15.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.6 | 42.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.6 | 11.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.6 | 14.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.6 | 9.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.5 | 16.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.5 | 9.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.5 | 3.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.5 | 12.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.5 | 0.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.5 | 13.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.4 | 0.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.4 | 15.3 | PID BMP PATHWAY | BMP receptor signaling |
0.4 | 4.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 14.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.4 | 0.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 10.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 1.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 43.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 3.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 4.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 2.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 2.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 24.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 2.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 2.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 1.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 1.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 2.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 0.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.1 | PID FGF PATHWAY | FGF signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 72.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
3.2 | 3.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
2.9 | 2.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
2.5 | 65.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
2.2 | 32.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
2.1 | 34.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
2.1 | 16.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
2.0 | 13.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.9 | 5.7 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.7 | 28.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.5 | 28.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
1.5 | 15.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.4 | 28.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.4 | 15.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.4 | 15.0 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
1.3 | 37.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.2 | 27.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.2 | 16.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.2 | 13.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.2 | 14.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.2 | 3.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.2 | 24.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.0 | 4.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.0 | 1.0 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
1.0 | 10.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.9 | 4.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.9 | 12.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.9 | 9.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.9 | 8.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.9 | 9.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.9 | 10.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.8 | 34.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.8 | 23.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.7 | 14.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.7 | 13.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.7 | 1.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.7 | 3.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.7 | 2.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.6 | 14.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.6 | 3.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.6 | 4.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.6 | 8.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.6 | 4.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.5 | 4.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.5 | 7.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.5 | 6.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.5 | 11.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.5 | 5.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.5 | 8.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.5 | 9.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.5 | 21.7 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.5 | 8.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.5 | 16.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.5 | 2.7 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.4 | 6.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.4 | 5.8 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.4 | 16.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.4 | 11.7 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.3 | 3.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.3 | 0.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 0.3 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.3 | 0.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.3 | 3.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.3 | 1.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 1.9 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.3 | 4.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 19.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.3 | 13.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 2.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 35.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.3 | 0.3 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.2 | 1.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.2 | 1.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 1.9 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 2.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 2.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 0.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 0.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 0.2 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.2 | 1.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 1.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 1.6 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.3 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 0.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 0.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 0.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 3.1 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 0.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.8 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 0.2 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.8 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 2.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.1 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.0 | 0.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.0 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.0 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |